Goldman Sachs Group Inc Igm Biosciences, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 1,259,230 shares of IGMS stock, worth $8.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,259,230
Previous 1,333,913 5.6%
Holding current value
$8.69 Million
Previous $9.16 Million 127.29%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.28 - $17.68 $469,009 - $1.32 Million
-74,683 Reduced 5.6%
1,259,230 $20.8 Million
Q2 2024

Aug 13, 2024
BUY
$6.51 - $11.47 $359,963 - $634,222
55,294 Added 4.32%
1,333,913 $9.16 Million
Q1 2024

May 15, 2024
BUY
$8.68 - $17.36 $2.07 Million - $4.13 Million
238,110 Added 22.88%
1,278,619 $12.3 Million
Q4 2023

Feb 13, 2024
BUY
$3.94 - $8.79 $2.3 Million - $5.13 Million
583,516 Added 127.69%
1,040,509 $8.65 Million
Q3 2023

May 14, 2024
SELL
$6.66 - $10.64 $3.89 Million - $6.21 Million
-583,516 Reduced 56.08%
456,993 $3.82 Million
Q3 2023

Nov 14, 2023
SELL
$6.66 - $10.64 $1.43 Million - $2.29 Million
-215,196 Reduced 32.01%
456,993 $3.82 Million
Q2 2023

May 14, 2024
BUY
$8.86 - $14.0 $2.47 Million - $3.9 Million
278,675 Added 70.82%
672,189 $6.2 Million
Q2 2023

Aug 14, 2023
BUY
$8.86 - $14.0 $2.47 Million - $3.9 Million
278,675 Added 70.82%
672,189 $6.2 Million
Q1 2023

May 14, 2024
BUY
$13.74 - $25.76 $2.67 Million - $5.01 Million
194,588 Added 97.82%
393,514 $5.41 Million
Q1 2023

May 11, 2023
BUY
$13.74 - $25.76 $2.67 Million - $5.01 Million
194,588 Added 97.82%
393,514 $5.41 Million
Q4 2022

May 14, 2024
SELL
$15.45 - $26.02 $777,799 - $1.31 Million
-50,343 Reduced 20.2%
198,926 $3.38 Million
Q4 2022

Feb 13, 2023
SELL
$15.45 - $26.02 $777,799 - $1.31 Million
-50,343 Reduced 20.2%
198,926 $3.38 Million
Q3 2022

May 14, 2024
BUY
$15.42 - $27.01 $782,025 - $1.37 Million
50,715 Added 25.54%
249,269 $5.67 Million
Q3 2022

Nov 10, 2022
BUY
$15.42 - $27.01 $782,025 - $1.37 Million
50,715 Added 25.54%
249,269 $5.67 Million
Q2 2022

May 14, 2024
SELL
$13.27 - $25.5 $11.2 Million - $21.5 Million
-841,955 Reduced 80.92%
198,554 $3.58 Million
Q2 2022

Aug 15, 2022
SELL
$13.27 - $25.5 $3.05 Million - $5.85 Million
-229,533 Reduced 53.62%
198,554 $3.58 Million
Q1 2022

May 16, 2022
BUY
$13.42 - $29.73 $328,293 - $727,284
24,463 Added 6.06%
428,087 $11.4 Million
Q4 2021

Feb 14, 2022
SELL
$27.59 - $66.39 $78,797 - $189,609
-2,856 Reduced 0.7%
403,624 $11.8 Million
Q3 2021

Nov 10, 2021
BUY
$65.76 - $90.65 $26.7 Million - $36.8 Million
406,480 New
406,480 $26.7 Million

Others Institutions Holding IGMS

# of Institutions
81
Shares Held
20.7M
Call Options Held
68K
Put Options Held
52.2K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $200M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email